| MEF2D — Myocyte Enhancer Factor 2D | |
|---|---|
| Symbol | MEF2D |
| Full Name | Myocyte Enhancer Factor 2D |
| Chromosome | 5q14.1 |
| NCBI Gene | 4209 |
| Ensembl | ENSG00000105509 |
| OMIM | 600663 |
| UniProt | Q01484 |
| Diseases | Parkinson's Disease, ALS, Neurodegeneration |
| Expression | Cerebral cortex, Hippocampus, Striatum, Cerebellum, Brainstem |
Mef2D — Myocyte Enhancer Factor 2D is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MEF2D (Myocyte Enhancer Factor 2D) is a gene located on chromosome 5q14.1 that encodes a critical transcription factor in neuronal development and function. MEF2D is a member of the myocyte enhancer factor-2 (MEF2) family of transcription factors, which play essential roles in neuronal survival, differentiation, synaptic plasticity, and activity-dependent gene expression.1
The gene is catalogued as NCBI Gene ID 4209 and OMIM 600663.
The MEF2D protein is a transcription factor that binds to the Mef2 response element (TTATTTATA) in the promoter region of target genes. It plays crucial roles in:
MEF2D is a key mediator of activity-dependent neuronal survival. It transduces survival signals in response to synaptic activity and neurotrophic factors. MEF2D promotes the expression of anti-apoptotic genes and protects neurons from various cytotoxic insults.1
MEF2D regulates genes involved in synaptic structure and function, including synaptic vesicle proteins, postsynaptic density proteins, and ion channels. It is involved in activity-dependent synaptic remodeling and long-term potentiation.2
MEF2D is widely expressed in the brain with high levels in:
Expression data is available from the Allen Human Brain Atlas.
MEF2D has been implicated in Parkinson's disease pathogenesis. Studies have shown that MEF2D activity is reduced in PD models and that restoring MEF2D function can protect dopaminergic neurons from cell death.3 MEF2D interacts with Parkin and PINK1, proteins mutated in familial PD, suggesting a role in mitochondrial quality control.
MEF2D dysfunction has been implicated in ALS. Research has shown that MEF2D is involved in regulating the expression of genes important for motor neuron survival, and its dysregulation contributes to motor neuron degeneration.4
MEF2D has also been implicated in:
The study of Mef2D — Myocyte Enhancer Factor 2D has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Page auto-generated from NeuroWiki gene database.